France · Delayed Price · Currency is EUR Neolife Statistics
Total Valuation
Neolife has a market cap or net worth of EUR 5.40 million. The enterprise value is 5.82 million.
| Market Cap | 5.40M |
| Enterprise Value | 5.82M |
Important Dates
The next estimated earnings date is Wednesday, September 23, 2026.
| Earnings Date | Sep 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Neolife has 96.37 million shares outstanding.
| Current Share Class | 96.37M |
| Shares Outstanding | 96.37M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 71.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 8.82 |
| P/OCF Ratio | 8.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.40, with an EV/FCF ratio of 9.51.
| EV / Earnings | n/a |
| EV / Sales | 0.47 |
| EV / EBITDA | 11.40 |
| EV / EBIT | n/a |
| EV / FCF | 9.51 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 8.14% |
| Revenue Per Employee | 565,545 |
| Profits Per Employee | -5,318 |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -79,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.68% in the last 52 weeks. The beta is 0.71, so Neolife's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -20.68% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 45.72 |
| Average Volume (20 Days) | 27,980 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Neolife had revenue of EUR 12.44 million and -117,000 in losses. Loss per share was -0.00.
| Revenue | 12.44M |
| Gross Profit | 4.89M |
| Operating Income | -168,000 |
| Pretax Income | -196,000 |
| Net Income | -117,000 |
| EBITDA | 510,520 |
| EBIT | -168,480 |
| Loss Per Share | -0.00 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | 612,000 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 679,000 |
| Net Borrowing | n/a |
| Free Cash Flow | 612,000 |
| FCF Per Share | 0.01 |
Margins
Gross margin is 39.32%, with operating and profit margins of -1.35% and -0.94%.
| Gross Margin | 39.32% |
| Operating Margin | -1.35% |
| Pretax Margin | -1.58% |
| Profit Margin | -0.94% |
| EBITDA Margin | 4.10% |
| EBIT Margin | -1.35% |
| FCF Margin | 4.92% |
Dividends & Yields
Neolife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2.17% |
| FCF Yield | 11.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |